Effect of simultaneous intravitreal ranibizumab and extended-release dexamethasone injection on patients with naïve versus refractory retinal vein occlusion macular edema: a prospective, multicenter, and interventional open-label study
In both naïve and refractory RVO-ME patients, IVR combined with Dex-I is effective. The initial combination therapy for naïve patients demonstrates more efficient improvement in BCVA and may reduce total injection numbers compared to refractory patients.
Authors
- Mingwei Zhao (ORCID: https://orcid.org/0000-0003-1370-6275)
- Huijun Qi
- Shanshan Li (ORCID: https://orcid.org/0000-0002-5905-5247)
- Heng Miao (ORCID: https://orcid.org/0000-0003-2510-5848)
- Tianzi Zhang (ORCID: https://orcid.org/0000-0002-4897-4328)
- Yaoyao Sun (ORCID: https://orcid.org/0000-0003-1333-570X)
- Qin Xiao
Institutions
- Inner Mongolia University for Nationalities (CN)
- Peking University (CN)
- Peking University People's Hospital (CN)
- Shandong Eye Hospital (CN)
- Qilu Hospital of Shandong University (CN)
- Beijing Information Science & Technology University (CN)
Publication Details
- Journal
- International Journal of Ophthalmology
- Published
- 2025-04-23
- DOI
- https://doi.org/10.18240/ijo.2025.05.11
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71